Cargando…

Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021

BACKGROUND: COVID-19 vaccines are an effective tool to prevent illness due to SARS-CoV-2 infection. However, infection after vaccination still occurs. We evaluated all infections identified among recipients of either the Pfizer-BioNTech or Moderna COVID-19 vaccine in five U.S. states during January–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadigh, Katrin S., Kugeler, Kiersten J., Bressler, Sara, Massay, Stephanie C., Schmoll, Emma, Milroy, Lauren, Cavanaugh, Alyson M., Sierocki, Allison, Fischer, Marc, Nolen, Leisha D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434543/ https://www.ncbi.nlm.nih.gov/pubmed/36050630 http://dx.doi.org/10.1186/s12879-022-07702-x

Ejemplares similares

COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
por: Birhane, Meseret, et al.
Publicado: (2021)

Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021
por: Kugeler, Kiersten J., et al.
Publicado: (2022)

Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
por: Payne, Jessica R., et al.
Publicado: (2023)

Association of Uninsurance and VA Coverage with the Uptake and Equity of COVID-19 Vaccination: January–March 2021
por: Gaffney, Adam W, et al.
Publicado: (2022)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
por: Pilishvili, Tamara, et al.
Publicado: (2021)

CRD Editor’s Corner Archive: January–March 2021
por: Steiner, Michael C
Publicado: (2021)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2020–November 2021
por: Sadigh, Katrin S., et al.
Publicado: (2022)

Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 – March 29, 2021
por: Nguyen, Kimberly H., et al.
Publicado: (2021)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015
por: Diop, Ousmane M., et al.
Publicado: (2015)

SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January–March 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021)

Associations of race/ethnicity and socioeconomic factors with vaccination among US adults during the COVID-19 pandemic, January to March 2021
por: Kim, Daniel
Publicado: (2022)

Progress Toward Poliomyelitis Eradication — Worldwide, January 2021–March 2023
por: Lee, Scarlett E., et al.
Publicado: (2023)

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
por: Scobie, Heather M., et al.
Publicado: (2021)

January-March 2009
Publicado: (2009)

January-March 2008
Publicado: (2008)

January-March 2007
Publicado: (2007)

January-March 1997
Publicado: (1997)

January-March 1998
Publicado: (1998)

January-March 1999
Publicado: (1999)

January-March 2001
Publicado: (2001)

January-March 2002
Publicado: (2002)

January-March 2003
Publicado: (2003)

January-March 2005
Publicado: (2005)

January-March 2006
Publicado: (2006)

January-March 1996
Publicado: (1996)

January-March 2010
Publicado: (2010)

SARS-CoV-2 Variants, South Sudan, January–March 2021
por: Bugembe, Daniel Lule, et al.
Publicado: (2021)

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
por: Tenforde, Mark W., et al.
Publicado: (2022)

Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021
por: Winner, Hannes, et al.
Publicado: (2022)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
por: Shirreff, George, et al.
Publicado: (2017)

Leveraging 13 million responses to the U.S. COVID-19 Trends and Impact Survey to examine vaccine hesitancy, vaccination, and mask wearing, January 2021-February 2022
por: Nguyen, Quynh C., et al.
Publicado: (2022)

Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021
por: Kwok, Kin On, et al.
Publicado: (2022)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
por: Alleman, Mary M., et al.
Publicado: (2021)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
por: Bigouette, John Paul, et al.
Publicado: (2023)

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
por: Tenforde, Mark W., et al.
Publicado: (2021)

Investigating the Marginal and Herd Effects of COVID-19 Vaccination for Reducing Case Fatality Rate: Evidence from the United States between March 2021 to January 2022
por: Li, Tenglong, et al.
Publicado: (2023)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021
por: Cavanaugh, Alyson M., et al.
Publicado: (2021)

SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 – June 30, 2021
por: Darby, Brandy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_scs5b6ritqj2qcqinvniuku5p5